Esophageal Cancer News
The daily esophageal cancer news is a unique cancer news service that evaluates all aspects of esophageal cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for esophageal cancer prevention, early detection and esophageal cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making esophageal cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Esophageal Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Esophageal Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
Second-line treatment with docetaxel improves overall survival of patients with advanced esophageal and gastric cancer, according to the results of a study presented at the 2013 Gastrointestinal Cancers... Continue Reading
Surgery after chemoradiotherapy—which is the standard of care in advanced esophageal cancer—increased overall and disease-free survival compared with chemoradiotherapy alone, according to the results... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
Patients who undergo surgery for esophageal cancer have a much higher chance of long-term survival if the surgeon has performed the operation many times before, according to the results of a study published... Continue Reading
The rate of esophageal cancer is on the rise worldwide, according to the results of a study published in GUT: An International Journal of Gastroenterology and Hepatology, but the onset and magnitude of... Continue Reading
Treatment with Iressa® (gefitinib) slowed disease progression and improved quality of life in patients with metastatic esophageal cancer, according to the results of a phase III trial presented at the... Continue Reading
Preoperative chemoradiotherapy doubled median overall survival among patients with esophageal or esophagogastric junction cancer compared to surgery alone, according to the results of a phase 3 study published... Continue Reading
Minimally invasive surgery may provide short-term benefits in resectable esophageal cancer, reducing the risk of pulmonary infection and improving quality of life, according to the results of a study published... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
Latest Esophageal Cancer News By Stage
Barrett's Esophagus
Surgeon Volume Influences Outcomes in Esophageal Cancer (February 6, 2013)
Patients who undergo surgery for esophageal cancer have a much higher chance of long-term survival if the surgeon has performed the operation many times before, according to the results of a study published in the Journal of Clinical Oncology. The esophagus... Continue Reading
Barrett’s Esophagus May Carry Lower Risk of Esophageal Cancer Than Previously Reported (July 8, 2011)Barrett’s esophagus—a condition characterized by abnormal cells in the lower part of the esophagus—may carry a lower risk of esophageal cancer than previously reported. These results were published in the Journal of the National Cancer Institute. The... Continue Reading
NSAIDS Reduce Risk of Esophageal Cancer (November 9, 2005)NSAIDS Reduce Risk of Esophageal Cancer According to a recent early on-line publication from Lancet Oncology, regular use of non-steroidal anti-inflammatory agents (NSAIDS) may reduce the risk of esophageal cancer among patients with Barrett’s esophagus. The... Continue Reading
Two Approaches to Reversing Barrett’s Esophagus May Be Successful (September 14, 2005)Two Approaches to Reversing Barrett’s Esophagus May Be Successful According to a brief report of study findings published in the journal Gastroenterology, roughly 70% of Barrett’s esophagus patients treated with multipolar electrocoagulation... Continue Reading
FDA Approves Photofrin® for Barrett’s Esophagus (August 11, 2003)FDA Approves Photofrin® for Barrett’s Esophagus The United States Food and Drug Administration (FDA) recently approved the photosensitizing agent Photofrin® to be used in photodynamic therapy for the treatment of pre-cancerous... Continue Reading
More Barrett's EsophagusScreening/Prevention
Esophageal Cancer on the Rise (November 12, 2012)
The rate of esophageal cancer is on the rise worldwide, according to the results of a study published in GUT: An International Journal of Gastroenterology and Hepatology, but the onset and magnitude of the increase varies among countries and even states. The... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Stay on Top of Your Family History of Cancer (July 15, 2011)People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading
Barrett’s Esophagus May Carry Lower Risk of Esophageal Cancer Than Previously Reported (July 8, 2011)Barrett’s esophagus—a condition characterized by abnormal cells in the lower part of the esophagus—may carry a lower risk of esophageal cancer than previously reported. These results were published in the Journal of the National Cancer Institute. The... Continue Reading
Cancer Risk May Rise Even with Moderate Drinking (April 15, 2011)People who currently consume alcohol or have done so in the past may have an increased risk of developing cancer, even those who drink moderately. These findings were recently reported in the journal BMJ. Worldwide, an estimated 3.5% of all cancer deaths... Continue Reading
More Screening/PreventionStages I-III
Surgery Improves Survival in Esophageal Cancer (February 21, 2013)
Surgery after chemoradiotherapy—which is the standard of care in advanced esophageal cancer—increased overall and disease-free survival compared with chemoradiotherapy alone, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading
Surgeon Volume Influences Outcomes in Esophageal Cancer (February 6, 2013)Patients who undergo surgery for esophageal cancer have a much higher chance of long-term survival if the surgeon has performed the operation many times before, according to the results of a study published in the Journal of Clinical Oncology. The esophagus... Continue Reading
Preoperative Chemoradiotherapy Improves Survival in Esophageal Cancer (September 10, 2012)Preoperative chemoradiotherapy doubled median overall survival among patients with esophageal or esophagogastric junction cancer compared to surgery alone, according to the results of a phase 3 study published in the New England Journal of Medicine. The... Continue Reading
Minimally Invasive Surgery a Viable Option for Esophageal Cancer (June 26, 2012)Minimally invasive surgery may provide short-term benefits in resectable esophageal cancer, reducing the risk of pulmonary infection and improving quality of life, according to the results of a study published in The Lancet. The esophagus is a muscular... Continue Reading
ERCC1 Levels Strongly Associated with Survival in Esophageal Cancer (June 13, 2011)Levels of expression of a specific gene (ERCC1 gene) are strongly associated with survival outcomes among patients with operable esophageal cancer undergoing platinum-based chemotherapy. Results such as these may help guide personalized treatment options... Continue Reading
More Stages I - IIIStage IV/Recurrent
Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)
Second-line treatment with docetaxel improves overall survival of patients with advanced esophageal and gastric cancer, according to the results of a study presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco. The esophagus is a muscular... Continue Reading
Surgery Improves Survival in Esophageal Cancer (February 21, 2013)Surgery after chemoradiotherapy—which is the standard of care in advanced esophageal cancer—increased overall and disease-free survival compared with chemoradiotherapy alone, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading
Iressa Improves Progression-Free Survival in Metastatic Esophageal Cancer (October 5, 2012)Treatment with Iressa® (gefitinib) slowed disease progression and improved quality of life in patients with metastatic esophageal cancer, according to the results of a phase III trial presented at the ESMO 2012 Congress of the European Society for Medical... Continue Reading
Factors Affecting Quality of Life at the End of Life (July 20, 2012)For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have less to do with medical treatment and more to do with a therapeutic alliance with their physicians, according to the results of... Continue Reading
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
More Stage IV/Recurrent
